Lori Houle
Corporate Officer/Principal presso NEUMORA THERAPEUTICS, INC.
Profilo
Lori Houle is currently the Chief Quality Officer at Neumora Therapeutics, Inc. She previously worked as the Head-Quality at Dermira, Inc. from 2014 to 2017 and as the Vice President-Global Quality at Vir Biotechnology, Inc. from 2017 to 2021.
Ms. Houle holds an MBA from DeVry University and an undergraduate degree from the University of Wisconsin.
Posizioni attive di Lori Houle
| Società | Posizione | Inizio |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2021 |
Precedenti posizioni note di Lori Houle
| Società | Posizione | Fine |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01/04/2021 |
| DERMIRA, INC. | Corporate Officer/Principal | 01/10/2017 |
Formazione di Lori Houle
| University of Wisconsin | Undergraduate Degree |
| DeVry University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Dermira, Inc. is a biopharmaceutical company. It engages in the provision of therapies for chronic skin conditions. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Indianapolis, IN. | Health Technology |
- Borsa valori
- Insiders
- Lori Houle